BioCentury
ARTICLE | Financial News

Pain company Heron raises $156M

March 29, 2018 4:29 PM UTC

Heron Therapeutics Inc. (NASDAQ:HRTX) raised $156 million via the sale of 6 million shares at $26 in a follow-on underwritten by Jefferies, Cowen, Evercore ISI, Cantor, JMP Securities, LifeSci Capital, Lake Street Capital Markets, National Securities, Noble Capital Markets and Northland Capital Markets.

The price is a 5% discount to Heron's Wednesday close of $27.50. The company announced and priced the offering after market hours, and then gained $0.10 to $27.60 on Thursday...